Search Orphan Drug Designations and Approvals
-
| Generic Name: | a fully human IgG1k anti-programmed death ligand-1 (PD-L1) monoclonal antibody |
|---|---|
| Date Designated: | 06/23/2025 |
| Orphan Designation: | treatment of progressive supranuclear palsy (PSP) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
ImmunoBrain Checkpoint Inc. 200 E. 61st Street, Suite 38F New York, New York 10065 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







